# Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension

> **NCT00548067** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 111 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Valsartan/hydrochlorothiazide (HCTZ)
- **DRUG:** Valsartan/amlodipine
- **DRUG:** Amlodipine/hydrochlorothiazide(HCTZ)
- **DRUG:** Valsartan/amlodipine/hydrochlorothiazide(HCTZ)

## Key facts

- **NCT ID:** NCT00548067
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** —
- **Final completion:** 2008-03
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2010-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00548067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00548067, "Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT00548067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*